Table 7. Bivariate analysis of association between ovarian reserve and biological, clinical and laboratory variables.
Variable Ovarian Reserve RR (95%CI) p value**
Low* Normal*
TAI (%)
Yes
No

32 (50.8)
52 (41.6)

31 (49.2)
73 (58.4)

1.22 (0.89 - 1.68)
1.0

0.222
Endometriosis (%)
Yes
No

23 (47.9)
61 (43.6)

25 (52.1)
79 (56.4)

1.10 (0.77 - 1.56)
1.0

0.596
Other autoimmune disease (%)
Yes
No

5 (71.4)
79 (43.6)

2 (28.6)
102 (56.4)

1.64 (0.99 - 2.69)
1.0
0.053
Anti-TPO (%)
Positive
Negative

25 (49.0)
59 (43.1)

26 (51.0)
78 (56.9)

1.14 (0.81 - 1.60)
1.0
0.456
Anti-Tg (%)
Positive
Negative

17 (60.7)
67 (41.9)

11 (39.3)
93 (58.1)

1.45 (1.02 - 2.06)
1.0
0.038
Age (years) (%)
< 35
35 - 39
> 39

12 (20.3)
36 (43.9)
36 (76.6)

47 (79.7)
46 (56.1)
11 (23.4)

1.0
2.16 (1.23 - 3.79)
3.77 (2.22 - 6.40)
<0.001

0.007
< 0.001
Obesity*** (%)
Yes
No

9 (52.9)
69 (43.8)

8 (47.1)
92 (57.1)

1.23 (0.76 - 2.0)
1.0
0.392

RR=relative risk; Anti-TPO=antithyroperoxidase; Anti-Tg=antithyroglobulin
* According to Poseidon´s criteria: low ovarian reserve=AMH < 1.2 ng/mL and/or AFC < 5 follicles;
** by Wald test; *** Obesity=IMC ≥ 30 (Kg/m2)